Analytical Data
-
基因名
CLSTN3
- Application
-
别名
CSTN3; CDHR14; CS3; Alc-beta; Cadherin-Related Family Member 14; Alcadein-beta
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BQT9
-
表达区间
Met1~Arg227
-
分子量
55kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLSTN3 (Calsyntenin 3) is a member of the calsyntenin family of proteins, which are characterized by their roles in synaptic function and neuronal development. Recent research has highlighted the significance of CLSTN3 in the context of neurodevelopmental disorders, including autism spectrum disorder (ASD) and schizophrenia. CLSTN3 is primarily localized at excitatory synapses in the central nervous system and has been implicated in various cellular processes such as endocytosis, synapse formation, and neuronal signaling. The study of CLSTN3 recombinant proteins has become pivotal for understanding its functional mechanisms, interactions with other synaptic proteins, and its contribution to neuronal pathologies. By generating and analyzing recombinant CLSTN3, researchers aim to elucidate its structure-function relationship, explore its role in synaptic plasticity, and assess the consequences of genetic mutations on its functionality. This line of investigation holds promise for unveiling potential therapeutic targets for treating neurodevelopmental disorders associated with dysregulated synaptic function.
